(6391) Nexcimer
Payments companies reported to CMS as associated with (6391) Nexcimer. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with (6391) Nexcimer, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with (6391) Nexcimer
These are the largest totals companies reported as associated with (6391) Nexcimer. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Nandish Thukral | San Antonio, TX | Interventional Cardiology | $595.23 |
| Douglas Rheam | Haddon Heights, NJ | Interventional Cardiology | $320.11 |
| Aaron Gopal | Spartanburg, SC | Interventional Cardiology | $304.29 |
| Craig Walker | Houma, LA | Interventional Cardiology | $259.01 |
| Anil Chagarlamudi | Houma, LA | Interventional Cardiology | $254.45 |
| Ryle Przybylowicz | Portland, OR | Clinical Cardiac Electrophysiology | $159.21 |
| Jamil Malik | San Antonio, TX | Interventional Cardiology | $131.70 |
| Quang Bui | Philadelphia, PA | Cardiovascular Disease | $130.80 |
| Thomas Riddell | Miramar Beach, FL | Cardiovascular Disease | $130.30 |
| John Altman | Lakewood, CO | Cardiovascular Disease | $125.00 |
Prescribed (6391) Nexcimer?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.